SCHEMBL24010073

SCHEMBL24010073

CC(=O)N1CCS(=N)(=O)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PIK3CD O00329 1/20 0.38
KMT2A Q03164 1/20 0.36
EPHX2 P34913 4/20 0.33
CASP6 P55212 1/20 0.33
GFER P55789 1/20 0.33
EPHX1 P07099 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
CHRNB3 Q05901 1/20 0.32
CHRNA6 Q15825 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3401340 0.80 CYP1A2 (0.56) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL12200680 0.76 CYP1A2 (0.52) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL26400830 0.76 CHRNB2 (0.38) SMN1; SMN2KMT2AALDH1A1CHRNB2CHRNA3
SCHEMBL24010084 0.76 BLM (0.41) TDP1KMT2AEPHX2EPHX1ALDH1A1
SCHEMBL19135562 0.76 USP2 (0.42) CYP1A2SMN1; SMN2KMT2AEPHX1ALDH1A1
SCHEMBL3401349 0.75 CYP1A2 (0.56) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL23987209 0.75 CYP1A2 (0.56) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL16362659 0.73 CYP1A2 (0.48) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL14407779 0.73 CYP1A2 (0.77) CYP1A2TDP1SMN1; SMN2KDM4EPIK3CD
SCHEMBL37407 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230190-A1 PYRIMIDINE BASED MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-11-30 WO disclosed
WO-2021225969-A1 IMINO SULFANONE INHIBITORS OF ENPP1 VOLASTRA THERAPEUTICS, INC. (US) 2021-11-11 WO disclosed